Efron Jonathan E, Young-Fadok Tonia M
Division of Colon and Rectal Surgery, Mayo Clinic, Scottsdale, AZ 85259, USA.
Clin Colon Rectal Surg. 2007 Nov;20(4):303-8. doi: 10.1055/s-2007-991029.
Patients with Crohn's disease often present to the surgeon for operative intervention in poor overall condition. They may be taking multiple immunomodulators to attempt to manage their disease, may have significant weight loss and evidence of malnutrition, and 10 to 30% of the time will have intraabdominal sepsis in the form of an abscess or fistula. Preoperative optimization of these patients, when possible, may decrease morbidity and mortality, and may avoid formation of stomas for fecal diversion. Enhancing nutritional status and streamlining immunomodulator therapy prior to surgery may improve outcomes. Medical management of intraabdominal sepsis with percutaneous drainage of abdominal or pelvic abscesses may decrease postoperative septic complications, and may even avert the need for surgical intervention altogether.
克罗恩病患者常常在全身状况较差时寻求外科手术干预。他们可能正在服用多种免疫调节剂来控制病情,可能出现显著体重减轻和营养不良迹象,并且10%至30%的情况下会出现腹腔内脓肿或瘘形式的脓毒症。在可能的情况下,对这些患者进行术前优化,可降低发病率和死亡率,并可避免因粪便转流而形成造口。术前改善营养状况并简化免疫调节剂治疗可能改善预后。通过经皮引流腹部或盆腔脓肿对腹腔内脓毒症进行内科治疗,可减少术后感染并发症,甚至可能完全避免手术干预的必要性。